Loading...
•
Dec 31, 2020
Zimmer Biomet Q4 2020 Earnings Report
Zimmer Biomet's Q4 2020 financial results were announced, revealing a slight decrease in net sales but a strong core business performance amidst COVID-19 pressures.
Key Takeaways
Zimmer Biomet reported Q4 net sales of $2.085 billion, a decrease of 1.9% compared to the prior year. Diluted earnings per share were $1.59, while adjusted diluted earnings per share were $2.11. The company also announced its intention to spin off its Spine and Dental businesses.
Fourth quarter net sales decreased by 1.9%, or 3.7% on a constant currency basis, reaching $2.085 billion.
Diluted earnings per share for the fourth quarter were $1.59, while adjusted diluted earnings per share amounted to $2.11.
Full-year net sales totaled $7.025 billion, representing a decrease of 12.0%, or 12.4% on a constant currency basis.
The company announced plans to spin off its Spine and Dental businesses to form a new, independent publicly traded company.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Due to the uncertainty surrounding the ongoing impact of COVID-19, the Company is currently unable to quantify the expected impact on its results of operations, financial condition and cash flows for full year 2021 and is not providing financial guidance at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...